A.Vento et al,
“Substance Use in the Club Scene of Rome: A Pilot Study”, BioMed Research International, Volume 2014, Article ID 617546,
http://dx.doi.org/10.1155/2014/617546

 

Archer J.R., Hudson, S., Jackson, O., Yamamoto, T., Lovett, C, Lee, H.M., Rao, S., Hunter, L., Dargan, P.I., and Wood, D.M. (2015).
Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use. QJM, March 2015.

 

Archer, J., Dargan, P., Lee, H., Hudson, S., and Wood, D. (2014).
Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clinical Toxicology, 52, 160–165. doi: 10.3109/15563650.2014.885982.

 

Auwärter, V., Angerer, V., Franz, F. (2015):
Analytik Räuchermischungen, Tabelle (spreadsheet ‚analytics herbal blends‘). Internal document, unreleased: Freiburg: University Medical Center.

 

Baggio, S., Studer, J, Mohler-Kuo, M, Daeppen, JB, Gmel, G. (2013)
Profiles of drug users in Switzerland and effects of early-onset intensive use of alcohol, tobacco and cannabis on other illicit drug use, Swiss Medical Weekly. No 143

 

Blackeart P; v Amsterdam J.G.C; Brunt T.M; vdn Berg J.D.J; v Durme F; Maudens K & v Brussels J.C.H. (2013)
4-Methyl-amphetamine : a health threat for recreational amphetamine user. Journal of Psychopharmacology 27(9) 817-822.

 

Borbála Paksi and Judit Sass,
A drogfogyasztás főbb mutatóinak alakulása a felnőtt népességben. Kutatási Beszámoló. Budapest: Corvinus Egyetem, 2014.

 

Brunt T.M & Niesink R.J.M (2011)
The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison. Drug testing and Analysis. DOI 10.1002/dta.323

 

Bücheli A & Menzi P. (2015)
Tätigkeitsbericht Safer Nightlife Schweiz 2013/2014, Bern: INFODROG Schweizerische Koordinations- und Fachstelle Sucht

 

Connolly, Johnny (2012)
Impact of legislation to control head shops. Drugnet Ireland, Issue 40, Winter 2011 p29.

 

Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P, Drummond C, Davey Z, Blaszko U, Moskalewicz J, Mervo B, Furia LD, Farre M, Flesland L, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, Sambola F, van der Kreeft P, Scherbaum N, Schifano F.,
Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol. 2013 Jul;28(4):317-23.

 

Corazza O; Assi S & Schifano, F. (2013),
From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine. CNS Neuroscience & Therapeutics, 19: 454–460. doi: 10.1111/cns.12063

 

Corazza, O., Assi, S., Trincas, G., Simonato, P., Corkery, J., Deluca, P., Davey, Z., Blaszko, U., Demetrovics, Z., Moskalewicz, J., Enea, A., di Melchiorre, G., Mervo, B., Fergus, S., Di Furia, L., Farre, M., Flesland, L., Pasinetti, M., Pesaresi, L., Pezzolesi, C., Pisarska, A., Scherbaum, N., Shapiro, H.,Siemann, H., Skutle, A., Stair, J., Sferrazza, E., Torrens, M., van der Kreeft, P., Zummo, D., & Schifano, F.,
Novel Drugs, Novel Solutions: exploring the potentials of web-assistance and multimedia approaches for the prevention of drug abuse. Italian Journal on Addiction, 2013, 1(1-2), 24-31.

 

Corazza, O., Demetrovics, Z., van den Brink, W., & Schifano, F.,
‘Legal highs’ an inappropriate term for ‘Novel Psychoactive Drugs’ in drug prevention and scientific debate. International Journal of Drug Policy, 2013, 24(1), 82-83.

 

Corazza, O., Schifano, F., Farre, M., Deluca, P., Davey, Z., Torrens, M., Demetrovics, Z., Di Furia, L., Flesland, L., Siemann, H., Skutle, A., Van Der Kreeft, P., Scherbaum, N.,
Designer drugs on the Internet: a phenomenon out-of-control? The emergence of hallucinogenic drug bromo-dragonfly. Current Clinical Pharmacology, 2011, 6(2), 125-129.

 

Csák R, Demetrovics D and Rácz J,
Transition to injecting 3, 4-methylene-dioxy-pyrovalerone (MDPV) among needle exchange program participants in Hungary. J Psychopharmacol 2013, 27,6:559-563.

 

Csák R, Demetrovics Z, Rácz J.,
Transition to injecting 3,4-methylene-dioxy-pyrovalerone (MDPV) among needle exchange program participants in Hungary. J Psychopharmacol. 2013 Jun;27(6):559-63.

 

De Donder, E. (2014).
Factsheet Smartdrugs & Nieuwe Psychoactieve Stoffen (NPS). Brussel: VAD.

 

DrogArt Counselling service internal report (2013).
http://www.drogart.org/svetovanje/1150/drogart-svetovalnica.html

 

DrogArt Counselling service internal report (2014).
http://www.drogart.org/svetovanje/1150/drogart-svetovalnica.html

 

DrogArt website.
www.drogart.org

 

Drug use among schoolchildren:
15–16 y o schoolchildren legal and illegal drugs use in Estonia, 2012, EST
https://intra.tai.ee/images/prints/documents/133846612537_Uimastite%20tarvitamine%20koolinoorte%20seas_raport.pdf

 

Drug Use And Related Risk Behaviors Anong Young People Visiting Nightclubs In Tallinn, 2010,
Tallinn University, EST
http://www.tai.ee/terviseandmed/uuringud?limit=0&filter_catid=15&filter_year=2010&filter_pubid=0&filter_languageid=0&filter=uimastite&filter_order=p.publish_year&filter_order_Dir=DESC

 

DrugScope. (2014).
Business as usual? A status report on new psychoactive substances (NPS) and club drugs in the UK. Retrieved from
http://www.drugscope.org.uk/Resources/Drugscope /Documents/PDF/Policy/BusinessAsUsual.pdf

 

E. Bertol, F. Mari, R.Boscolo Berto, G. Mannaioni, F. Vaiano, D. Favretto,
“A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC–HRMS and discussion of the case”, Forensic Science International 243 (2014): 149–155.

 

E. Chillemi, G. Martinotti, L. Bonifaci, R. Santacroce, E. Cinosi, M. Lupi, L. Janiri, M. Di Giannantonio,
“Epidemiology of novel psychoactive substances in an Italian sample”, P.6.c. Addiction − Drugs (basic): S683.

 

E.Gerace et al,
“Toxicological findings in a fatal multidrug intoxication involving mephedrone”, Forensic Science International, October 2014, Volume 243: 68–73

 

EMCDDA (2011).
Online sales of new psychoactive substances / 'legal highs': summary of results from the 2011 multilingual snapshots. Brief Paper.
Available: http://www.emcdda.europa.eu/publications/scientific-studies/2011/snapshot

 

EMCDDA (2012a). 2011 NATIONAL REPORT (2010 data) TO THE EMCDDA by the Reitox National Focal Point SLOVAKIA New Development,
Trends and In-depth Information on Selected Issues. Bratislava: Slovak Republic Government Office General Secretariat of the Board of Ministers for Drug Dependencies and Drug Control, National monitoring centre for drugs.

 

EMCDDA (2013). 2012 NATIONAL REPORT (2011 data) TO THE EMCDDA by the Reitox National Focal Point SLOVAKIA New Development,
Trends and In-depth Information on Selected Issues. Bratislava: Slovak Republic Government Office General Secretariat of the Board of Ministers for Drug Dependencies and Drug Control, National monitoring centre for drugs.

 

EMCDDA (2014),
European Drug Report 2014: Trends and developments, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

 

EMCDDA (2015)
Country Legal Profile: Cyprus. Retrieved on May 15th 2015 from
http://www.emcdda.europa.eu/html.cfm/index5174EN.html?pluginMethod=eldd.countryprofiles&country=CY

 

EMCDDA (2015).
New psychoactive substances in Europe: An update from the EU Early Warning Systém. March 2015.
Available: http://www.emcdda.europa.eu/news/2015/1/cnd-new-drugs

 

EMCDDA Country overview:
Estonia 2013 ENG http://www.emcdda.europa.eu/publications/country-overviews/ee

 

European Commission. (2014).
Flash Eurobarometer 401. Young people and drugs. European Commission

 

European Monitoring Centre for Drugs and Drug Addiction. (2009).
EMCDDA Action on new drugs briefing paper: Understanding the “Spice” phenomenon (a report from an EMCDDA expert meeting). Lisbon: European Monitoring Centre for Drugs and Drug Addiction

 

Flash Eurobarometer 401. (2014).
YOUNG PEOPLE AND DRUGS. European Commission, Directorate-General for Justice and co-ordinated by the Directorate-General for Communication.

 

G.Frison et al,
“A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract”, Forensic Science International, August 6, 2008 Volume 179, Issues 2-3 : e37–e43

 

Giné, C.V., Espinosa, IF, Vilamala, MV.(2014).
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?Drug Test Anal. 2014 Jul-Aug;6(7-8):819-24. doi: 10.1002/dta.1610

 

Gmel G., Kuendig H., Notari L., Gmel C. (2014).
Monitorage suisse des addictions : consommation d’alcool, tabac et drogues illégales en Suisse en 2013. Addiction Suisse, Lausanne

 

GÖG/ÖBIG (2012): 2012
national report to the EMCDDA by the National Reitox Focal Point Austria. New development, trends and in-depth information on selected issues. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG. Vienna

 

GÖG/ÖBIG (2014a):
Report on the Drug Situation 2014. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG. Vienna

 

GÖG/ÖBIG (2014b):
Epidemiologiebericht Drogen 2014. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG. Im Auftrag des Bundesministeriums für Gesundheit. Vienna

 

Home Office. (2011).
Drug Misuse Declared: Findings from the 2010 to 2011 British Crime Survey. Retrieved from the UK Government website:
www.gov.uk/government/uploads/system/ uploads/attachment_data/file/116333/hosb1211.pdf

 

Home Office. (2012).
Drug Strategy: Annual review. Retrieved from the UK Government website:
www.gov.uk/government/publications/annual-review-of-the-drug-strategy-2010

 

Home Office. (2013).
Drug Misuse: Findings from the 2012 to 2013 Crime Survey for England and Wales. Retrieved from the UK Government website:
www.gov.uk/government/publications/

 

Home Office. (2014a).
Drug Misuse: Findings from the 2013/14 Crime Survey for England and Wales. Retrieved from the UK Government website:
www.gov.uk/government/uploads/system/uploads/attachment_data/file/335989/drug_misuse_201314.pdf

 

Home Office. (2014b).
Annual Report on the Home Office Forensic Early Warning System (FEWS). A System to Identify New Psychoactive Substances in the U. Retrieved from the UK Government website:
www.gov.uk/government/uploads/system/uploads/attachment_data/file/344551/ 2014-08-12_-_FEWS_Annual_Report_Aug_2014_-_Final__2_.pdf

 

Home Office. (2014c).
New psychoactive substances review: report of the expert panel. Retrieved from the UK Government website:
www.gov.uk/government/publications/new-psychoactive-substances-review-report-of-the-expert-panel

 

Home Office. (2015a).
Guidance for local authorities on taking action against head shops selling new psychoactive substances - working with local partners. Retrieved from the UK Government website:
www.gov.uk/government/uploads/system/uploads/attachment_data/file/410961/ Guidance_for_local_authorities_on_taking_action_against_10.03_15.pdf

 

Home Office. (2015b).
New Psychoactive Substances (NPS) resource pack. Retrieved from the UK Government website:
www.gov.uk/government/publications/new-psychoactive-substances-nps-resource-pack

 

Home Office. (2015c).
Blanket ban to clamp down on 'legal highs'. Retrieved from the UK Government website:
www.gov.uk/government/news/blanket-ban-to-clamp-down-on-legal-highs

 

Home Office. (n.d).
Temporary Class Drugs. Retrieved from the UK Government website:
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/98006/temporary-class-drug-factsheet.pdf

 

Hondebrink L; Nutgeren-van Lonkhuyzen J.J; Van der Gouwe D & Brunt T.M. (2014).
Monitoring new psychoactive substances (NPS) in the Netherlands: Data from the drug market and the Poisons Information Centre. [Drug and alcohol Dependence 147(2015)109-115.
http://www.pnsd.msc.es/Categoria2/publica/pdf/Nuevas_sustancias_espanol.pdf

 

ISEC (2013)
“New psychoactive substances (NPS): Building knowledge and evidence based training through research”. Retrieved on May 10th, 2015 from
http://www.iseccyproject.com/assets/Summary_ISEC72626.pdf

 

Kapitány-Fövény M, Kertész M, Winstock A, Deluca P, Corazza O, Farkas J, Zacher G, Urbán R, Demetrovics Z.,
Substitutional potential of mephedrone: an analysis of the subjective effects.Hum Psychopharmacol. 2013 Jul;28(4):308-16.

 

Kapitány-Fövény Máté, Farkas Judit, Csorba József , Szabó Tünde ,
Demetrovics Zsolt, Különbségek a szintetikus kannabinoidok és a kannabisz szubjektív hatásaiban, a használati mintázatban és a használat okaiban . A MAGYAR ADDIKTOLÓGIAI TÁRSASÁG IX. ORSZÁGOS KONGRESSZUSA SIÓFOK, 2013. NOVEMBER 21–23. ELŐADÁSKIVONATOK. 25.o.

 

Kaupe R. (2012).
Kas ir kaitējuma mazināšana? Programmu darbības pamatprincipi un filozofija
http://www.diacentrs.lv/public/uploads/files/pdf/Kas_ir_kaitejuma_mazinasana_Final1.pdf

 

Kelleher, C., R. Christie, et al. (2011).
An overview of new psychoactive substances and the outlets supplying them. Dublin, National Advisory Committee on Drugs.

 

Koning R & Niesink R(2013)
Nieuwe Psychoactieve Stoffen (NPS): niets nieuws onder de zon. DIMS publications.

 

Koroļeva I., Trapencieris M., Sniķere S., Kārkliņa I., Jankovskis M., Krieķe L. (2012).
Narkotiku lietošana izklaides vietās 2012. gadā. Pētījuma rezultāti. Rīga: Slimību profilakses un kontroles centrs

 

Kovčo Vukadin, I. (2014).
Survey on student life quality in Croatia. Research Report. Internal material of the Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

L. Zamengo, G. Frison, C. Bettin, R. Sciarrone,
„Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products“, Toxicology letters, 229 (2014): 220–228

 

M.Aromatario, E. Bottoni, M.Santoni, C. Ciallella,
“New ‘‘Lethal highs’’: A case of a deadly cocktail of GHB and Mephedrone”, Forensic Science International 223 (2012): e38-e41.

 

Maier L, Bachmann A, Bücheli A, Schaub M.
Erarbeitung Instrumente zur Früherkennung und Frühintervention von problematischem Substanzkonsum im Schweizer Nachtleben (2011-2013). ISGF, Zürich, 2014

 

Malta National Focal Point (2013),
2012 National Report- Malta Drug Situation, ISBN: 978-99957-0-558-9.

 

Morgenstern C, Werse B & Sarvari L. (2012)
Bericht zur Online-Umfrage zu Legal Highs, Schweiz Goethe-Universität, Frankfurt am Main

 

Móró L, Rácz J.,
Online drug user-led harm reduction in Hungary: a review of "Daath". Harm Reduct J. 2013 Oct 2;10:18.

 

Móró, L.,
Harm reduction of novel psychoactive substance use.

 

In G. R. Potter, M. Wouters & J. Fountain (Eds.),
Change and Continuity: researching evolving drug landscapes in Europe (pp. 36-50). Lengerich: Pabst Science Publishers, 2014.

 

Móró, L., Simon, K., Sárosi, P. (2013):
Drug use among sex workers in Hungary. Social Science & Medicine, 93, 64-69.

 

National Aids Trust. (2013).
HIV and Injecting Drug Use. July 2013. National Aids Trust. Retrieved from
www.nat.org.uk/media/Files/Policy/2013/HIV_and_Injecting_Drug_Use_Report_2013.pdf

 

National Treatment Agency. (2012).
Club drugs: emerging trends and risks. National Treatment Agency for Substance Misuse. Retrieved from
http://www.nta.nhs.uk/uploads/clubdrugsreport2012%5B0%5D.pdf

 

New psychoactive substances-what they are and how to deal with them, by Katri-Abel-Ollo,
National Institut for Health Development, 2014, EST
http://www.raplamv.ee/tervis/wp-content/uploads/2014/01/Uued-ps%C3%BChhoaktiivsed-ained-Katri-Abel-Ollo.pdf

 

Péterfi A, Tarján A, Horváth GC, Csesztregi T, Nyírády A.,
Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones. Drug Test Anal. 2014 Jul-Aug;6(7-8):825-31.

 

Pidd, H. (2013).
Manchester’s Warehouse Project club introduces drug testing pilot scheme. The Guardian, Sunday 1 December, 2013. Retrieved from
http://www.theguardian.com/society/2013/dec/01/drug-testing-warehouse-project-nightclub

 

Pihlainen, K. 2015.
Ajankohtaista huumausainelainsäädännössä: kuluttajamarkkinoilta kielletyt psykoaktiiviset aineet. Article published in Sic!-magazine 1/2015, available at
http://sic.fimea.fi/1_2015/ajankohtaista_huumausainelainsaadannossa.

 

Prop e.V. (2015):
Prop e.V. Drogennotdienst L43 - Auszug aus der Klient_innenbefragung 2014. Internal document, unreleased.

 

Racz J, Csak R, Farago R, Vadasz V:
[The phenomenon of drug change in the interviews with injecting drug users.]A drogváltás jelensége injekciós droghasználókkal készült interjúkban, PSYCHIATRIA HUNGARICA 27: (1) pp. 29-47.

 

Rácz J, Csák R, Lisznyai S:
Transition from ‘‘old’’ injected drugs to mephedrone in an urban micro segregate in Budapest, Hungary: a qualitative analysis, JOURNAL OF SUBSTANCE USE In press: p. In press. 9 p.

 

Rácz J.,
[Relapse prevention in drug addicts]. Neuropsychopharmacol Hung. 2013 Dec;15(4):232-8. Review. Hungarian.

 

Rácz J., Csák R.,
Emergence of novel psychoactive substances among clients of a needle exchange programme in Budapest. Orvosi Hetilap 2014 155 (35): 1383-1394.

 

Rácz, József, Gyarmathy, V. Anna, Csák, Róbert,
New cases of HIV among PWIDs in Hungary: false alarm or early warning? International Journal of Drug Policy, In Press, Accepted Manuscript, 23 June 2015.

 

Reitox Focal Point;
report to the EMCDDA by the Reitox Focal Point; The Netherlands Drugs Situation 2013

 

REITOX National Focal Point,
Annual Reports. 2010-2014.
http://drogfokuszpont.hu/eves-jelentesek

 

Report on the drug situation 2014 of the Republic of Slovenia (2014).
http://www.nijz.si/publikacije/nacionalno-porocilo-o-stanju-na-podrocju-drog-2014-v-angleskem-jeziku

 

Sárosi, Péter,
The Not-So-Balanced Approach. Policy Responses to New Psychoactive Substances. Budapest: HCLU, 2014.

 

Schaub M & Bücheli A (2014)
GDS Daten Switzerland 2014. Presented in Zürich on the 11.04.2014

 

Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., Farre, M., Torrens, M., Demetrovics, Z., Ghodse, A. H.,
Psychonaut Web Mapping, ReDNet Research Groups. Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues. Psychopharmacology, 2011, 214(3), 593-602.

 

SI-EWS
monthly report April. E-mail communication. 2015.

 

Smith, S.W. and Garlich, F.M. (2013).
Availability and Supply of Novel Psychoactive Substances. In: Dargan, P.I. and Wood, D.M. (Eds). (2013). Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, pp.55–77. London: Academic Press.

 

Sniķere S., Trapencieris M., Koroļeva I., Mieriņa I., Priekule S., Aleksandrovs A., Jankovskis M. (2012).
Atkarību izraisošo vielu lietošana iedzīvotāju vidū 2011. Analītisks pārskats. Rīga: Nacionālais veselības dienests

 

Szily, E., Bitter, I.,
Designer drugs in psychiatric practice – A review of the literature and the recent situation in Hungary, Neuropsychopharmacol Hung, 2013, 15(4): 223-231.

 

Tammi, T., Pitkänen, T. & Perälä, J. (2011)
Stadin nistit – huono-osaisten helsinkiläisten huumeidenkäyttäjien päihteet sekä niiden käyttötavat ja hankinta. Yhteiskuntapolitiikka 76(1), 45-54.

 

Tarján, A., Dudás, M., Gyarmathy, V. A., Rusvai, E., Tresó, B., & Csohán, Á.,
Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times. Substance Use & Misuse, 2013, 0(0), 1-11.

 

The Gallup Organization (2011):
Flash Eurobarometer 330 – Youth attitudes on drugs. Analytical Report. (On Behalf of the European Commission). Budapest: The Gallup Organization.

 

Trapencieris M. (2013).
Alkohola, tabakas un narkotiku lietošanas izplatība skolēnu vidū Latvijā. Metodoloģiskā pētījuma rezultāti. Rīga: Slimību profilakses un kontroles centrs

 

Trapencieris M., Sniķere S., Koroļeva I., Kārkliņa I. (2012). ESPAD 2011.
Atkarību izraisošo vielu lietošanas paradumi un tendences skolēnu vidū. Rīga: Slimību profilakses un kontroles centrs

 

Trapencieris M., Sniķere S., Pētersons A., Kaupe R. (2013).
Narkotiku lietošanas paradumi un tendences Latvijā. Narkotiku lietotāju kohortas pētījuma 6. posma rezultāti. Rīga: Slimību profilakses un kontroles centrs, DIA+LOGS

 

Trapencieris M., Sniķere S., Pētersons A., Kaupe R. (2014).
Narkotiku lietošanas paradumi un tendences Latvijā. Narkotiku lietotāju kohortas pētījuma 7. posma rezultāti. Rīga: Slimību profilakses un kontroles centrs, DIA+LOGS

 

Trapencieris M., Sniķere S., Pētersons A., Kaupe R. (2015).
Narkotiku lietošanas paradumi un tendences Latvijā. Narkotiku lietotāju kohortas pētījuma 8. posma rezultāti. Rīga: Slimību profilakses un kontroles centrs, DIA+LOGS

 

Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. (2010).
"Chemical analysis of synthetic cannabinoids as designer drugs in herbal products". Forensic Science International 198 (1–3): 31–8.

 

United Nations Office on Drugs and Crime (2014).
The Global Smart Programme.

 

United Nations Office on Drugs and Crime,
World Drug Report 2013.

 

United Nations Office on Drugs and Crime. (2013).
World Drug Report. Retrieved from the UNODC website:
www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf

 

United Nations(1971). Convention on Psychotropic Substances. Available:
http://www.unodc.org/pdf/convention_1971_en.pdf

 

UNODC (2013).
International Standards on Drug Use Prevention. Vienna: UNODC.

 

UNODC(2014).
NPS substance groups. Available:
https://www.unodc.org/LSS/SubstanceGroup/GroupsDashboard?testType=NPS

 

UNODOC (2013):
The challenges of new psychoactive substances. A Report from the Global SMART Programme. March 2013. Vienna

 

Utoslahti, K. 2014.
Muuntohuumeet huolestuttavat ammattilaisia ja käyttäjiä. Tiimi 3/2014.

 

Uvodić-Đurić, D., Bacinger Klobučarić, B., Kutnjak Kiš, R. (2014).
It is good to know - Results of the survey regarding attitudes, habits and addictive substance use among school children and young persons in the Međimurje County. Čakovec: Međimurje County Institute of Public Health.

 

v Amsterdam J.G.C; Nutt D & vdn Brink W. (2013)
Generic legislation of new psychoactive drugs. Journal of Psychopharmacology. DOI: 10.1177/0269881112474525

 

v Amsterdam J.G.C & Pennings E.J.M. (2013)
Wettelijke mogelijkheden om het gebruik van designer drugs tegen te gaan. Rijksinstituut voor Volksgezondheid en Milieu.

 

v Amsterdam J.G.C; v Laar M; Brunt T.M & vdn Brink W. (2012)
Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regulatory Toxicology and Pharmacology. Volume 63 issue 1. P. 55-63

 

Vugrinec L., Bošnjak A., Jerković D. (2009).
Croatian Report on the Drugs Situation 2009. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Jerković D., Markelić M., Markus M., Ivandić Zimić J., Mikulić S., Vukičević N., Andreić J.(2011).
Croatian Report on the Drugs Situation 2011. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Jerković D., Markelić M., Markus M., Ivandić Zimić J., Mikulić S., Vukičević N., Andreić J.(2012).
Croatian Report on the Drugs Situation 2012. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Jerković D., Markelić M., Markus M., Ivandić Zimić J., Mikulić S., Vukičević N., Andreić J., Klarić D., Bagarić S. (2013).
Croatian Report on the Drugs Situation 2013. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Jerković D., Markus M., Ivandić Zimić J., Mikulić S., Vukičević N., Andreić J., Tičinović B., Fulir, M. (2014).
Croatian Report on the Drugs Situation 2014. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Jerković D., Pejak M., Čorić T., Markus M. (2010). Croatian Report on the Drugs Situation 2010.
Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Laušić H., Bošnjak A., Katalinić D., Orlić M., Dundović D., Kolarić B., Lakić M. (2008).
Croatian Report on the Drugs Situation 2008. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Vugrinec L., Laušić H., Kuzman M., Katalinić D., Čorić T., Cahunek Žunec M., Petković Ž. (2007).
Croatian Report on the Drugs Situation 2007. Zagreb: Office for Combating Drug Abuse of the Government of the Republic of Croatia.

 

Welsh Government. (2013).
Working together to reduce harm: Substance misuse strategy Annual report 2013. Retrieved from the Welsh Government website:
http://gov.wales/docs/dhss/publications/131030submisuseprogressreporten.pdf

 

Werse, B. & Egger, D. (2015): MoSyD-Szenestudie 2014.
Frankfurt: Goethe University, Centre for Drug Research.
http://www.uni-frankfurt.de/51782988/MoSyD_Szenestudie_2014.pdf (01.04.2015)

 

Werse, B. & Morgenstern, M. (2015):
Der Trend geht zur Reinsubstanz - Entwicklungen im Konsum von "Legal Highs"/neuen psychoaktiven Substanzen (NPS) auf Basis zweier Online-Befragungen. Suchttherapie, 16: 36-41

 

Werse, B. & Müller, O. (2009):
Spice, Smoke, Sence & Co. – Cannabinoidhaltige Räuchermischungen: Konsum und Konsummotivation vor dem Hintergrund sich wandelnder Gesetzgebung.
http://www.uni-frankfurt.de/51784230/Spice_Smoke_Sence_Pilotstudie.pdf (16.03.2015)

 

Werse, B. (2014):
Zur Verbreitung von neuen psychoaktiven Substanzen (NPS), in: akzept e.V. „Alternativer Sucht- und Drogenbericht 2014“: 22-26

 

Werse, B., Morgenstern, C. & Sarvari, L. (2014):
MoSyD – Jahresbericht 2013. Frankfurt: Goethe University, Centre for Drug Research.
http://www.uni-frankfurt.de/52060909/MoSyD_Jahresbericht-2013_final.pdf (16.03.2015)

 

Windelinckx, T. (2014).
Evaluatierapport Spuitenruil werkjaar 2013. Antwerpen: Free Clinic.

 

Windelinckx, T. (2015).
Evaluatierapport Spuitenruil werkjaar 2014. Antwerpen: Free Clinic.

 

Zareff, A. & Hietanen E. 2014.
Muuntohuumeiden uusin ilmiö: synteettistä kannabista sähkösavukkeessa. MTV Uutiset/Rikos, 07.04.2014.

 

Zareff, Anna 2014.
Mikä tahansa kelpaa – nuori narkomaani pitää itseään kokeilualustana. MTV3 10.4.2014.

 

Zimmermann, R. (2015):
Spreadsheet on NPS use among PUDH from the „Druck-Studie“, internal document, unreleased.

 

 

 

Defining NPS

New to Whom?

UNODC defines new psychoactive substancesor NPS as:... read more

 

Defining Target Groups

Defining the Project’s target audience or end beneficiaries comes with considerable difficulties. The official project title... read more

 

 

publications

 

Project News

nps mini

Addictology, the Czech based journal for research into addiction, published a special issue on NPS related articles, including those with the outcomes of the NPS in Europe project.
read more...

nps mini

The NPS staff presented project outcomes at the International Harm Reduction Conference in Kuala Lumpur, Malaysia.
read more...


nps mini
SEMINAR
NPS Policy: Moving Forward
Leading European experts, including researchers, practitioners and policy makers will meet at a Seminar in Lisbon on the 26th of November to discuss the latest developments in the field of New Psychoactive Substances (NPS).
read more...

nps mini
The NPS in Europe project organises a training on new psychoactive substances (nps), 23 - 25 November 2015 in Lisbon, Portugal. The training is aimed at service provider and peers, supporting NPS users in Europe. The course will give an overview of relevant NPS substances, identify current patterns and develop effective harm reduction service responses.
read more..

Practical information...


nps mini
NPS in Europe

is launching a questionnaire on NPS use in all European countries.